Computer-based Cognitive Training for Individuals With Parkinson's Disease
Trial
N/A
Completed
Jan. 7, 2016
Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's Disease - BeatPark Study
Trial
N/A
Unknown
Jan. 7, 2016
DBS Under General Anesthesia: Comparison To The Standard Technique
Trial
N/A
Completed
Dec. 31, 2015
Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Trial
Early Phase 1
Completed
Dec. 30, 2015
Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
Trial
Phase 4
Completed
Dec. 29, 2015
Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067
Trial
Phase 1
Completed
Dec. 23, 2015
Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics
Trial
Phase 1
Completed
Dec. 23, 2015
Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients
Trial
Phase 2
Completed
Dec. 23, 2015
Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa
Trial
Phase 1
Completed
Dec. 21, 2015
Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin
Trial
Phase 1
Completed
Dec. 21, 2015
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Trial
Phase 4
Completed
Dec. 17, 2015
Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity Measured Through Implanted Stimulators
Trial
Phase 4
Completed
Dec. 17, 2015
Perceptual Decision Making Under Conditions of Visual Uncertainty
Trial
N/A
Unknown
Dec. 17, 2015
Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
Trial
Phase 1
Completed
Dec. 15, 2015
PD4PD:Partnered Dance for Parkinson Disease
Trial
Phase 2
Completed
Dec. 8, 2015
Vascular Abnormalities in Idiopathic Parkinson's Disease
Trial
N/A
Unknown
Dec. 1, 2015
Web-based International Multi-Center Clinical Study for Parkinson's Disease
Trial
N/A
Unknown
Nov. 29, 2015
Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study
Trial
Phase 2
Withdrawn
Nov. 23, 2015
Treatment of Depression in Parkinson's Disease Trial
Trial
Phase 2
Completed
Nov. 23, 2015